Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma

被引:0
|
作者
Pinnix, Chelsea C. [1 ]
Dabaja, Bouthaina S. [2 ]
Gunther, Jillian R. [2 ]
Fang, Penny [2 ]
Wu, Susan [2 ]
Nastoupil, Loretta [3 ]
Strati, Paolo [3 ]
Nair, Ranjit [4 ]
Ahmed, Sairah [5 ]
Steiner, Raphael E. [6 ]
Malpica-Castillo, Luis [7 ]
Chihara, Dai [8 ]
Jain, Preetesh [9 ]
Fayad, Luis [10 ]
Westin, Jason R. [11 ]
Neelapu, Sattva S. [3 ]
Rodriguez, Maria Alma [5 ]
Hagemeister, Fredrick B. [10 ]
Lee, Hun Ju [3 ]
Wang, Michael [12 ]
Samaniego, Felipe [3 ]
Fowler, Nathan H. [13 ]
Flowers, Christopher R. [6 ]
Feng, Lei [14 ]
Chi, Linda [13 ]
Esmaeli, Bita
机构
[1] MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[4] MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA
[5] MD Anderson Canc Ctr, Houston, TX USA
[6] MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Univ New Mexico, Hlth Sci Ctr, Dept Leukemia, Albuquerque, NM 87131 USA
[9] UTMDACC, Dept Lymphoma & Myeloma, Houston, TX USA
[10] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[11] MD Anderson, Dept Lymphoma & Myeloma, Houston, TX USA
[12] UT MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA
[13] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[14] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2021-154172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3526
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [31] Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: A phase II study
    Murthy, Vedang
    Thomas, Karen
    Foo, Kerwyn
    Cunningham, David
    Johnson, Bernadette
    Norman, Andrew
    Horwich, Alan
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (04): : 241 - 245
  • [32] Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trials
    Solh, Melhem
    Fisher, Richard I.
    Goy, Andre
    de Vos, Sven
    Bernstein, Steven H.
    Esseltine, Dixie-Lee
    Neuwirth, Rachel
    Morrison, Vicki A.
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2185 - 2189
  • [33] High Dose Methotrexate Based Chemotherapy and Response Adapted Whole Brain Radiation Therapy in Primary CNS Lymphoma
    Biswas, A.
    Adhikari, N.
    Gogia, A.
    Sahoo, R.
    Garg, A.
    Sharma, M.
    Bhasker, S.
    Sreenivas, V.
    Kumar, L.
    Chander, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S192 - S192
  • [34] Phase II trial of bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or elderly mantle cell lymphoma in Japan.
    Ishizawa, Kenichi
    Ogura, Michinori
    Maruyama, Dai
    Abe, Yasunobu
    Ando, Kiyoshi
    Izutsu, Koji
    Terui, Yasuhito
    Yoshitaka, Imaizumi
    Fukuhara, Noriko
    Uchida, Toshiki
    Choi, Ilseung
    Ohmachi, Ken
    Yamamoto, Go
    Tobinai, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
  • [36] Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan
    Ogura, Michinori
    Ishizawa, Kenichi
    Maruyama, Dai
    Uike, Naokuni
    Ando, Kiyoshi
    Izutsu, Koji
    Terui, Yasuhito
    Imaizumi, Yoshitaka
    Tsukasaki, Kunihiro
    Suzuki, Kenshi
    Izumi, Tohru
    Usuki, Kensuke
    Kinoshita, Tomohiro
    Taniwaki, Masafumi
    Uoshima, Nobuhiko
    Suzumiya, Junji
    Kurosawa, Mitsutoshi
    Nagai, Hirokazu
    Uchida, Toshiki
    Fukuhara, Noriko
    Choi, Ilseung
    Ohmachi, Ken
    Yamamoto, Go
    Tobinai, Kensei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (04) : 470 - 477
  • [37] Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan
    Michinori Ogura
    Kenichi Ishizawa
    Dai Maruyama
    Naokuni Uike
    Kiyoshi Ando
    Koji Izutsu
    Yasuhito Terui
    Yoshitaka Imaizumi
    Kunihiro Tsukasaki
    Kenshi Suzuki
    Tohru Izumi
    Kensuke Usuki
    Tomohiro Kinoshita
    Masafumi Taniwaki
    Nobuhiko Uoshima
    Junji Suzumiya
    Mitsutoshi Kurosawa
    Hirokazu Nagai
    Toshiki Uchida
    Noriko Fukuhara
    Ilseung Choi
    Ken Ohmachi
    Go Yamamoto
    Kensei Tobinai
    International Journal of Hematology, 2017, 105 : 470 - 477
  • [38] Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma
    Kelsey, Chris R.
    Broadwater, Gloria
    James, Olga
    Chino, Junzo
    Diehl, Louis
    Beaven, Anne W.
    Chang, Catherine
    Koontz, Bridget F.
    Prosnitz, Leonard R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : 96 - 101
  • [39] A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
    Yazbeck, Victor
    Shafer, Danielle
    Perkins, Edward B.
    Coppola, Domenico
    Sokol, Lubomir
    Richards, Kristy L.
    Shea, Thomas
    Ruan, Jia
    Parekh, Samir
    Strair, Roger
    Flowers, Christopher
    Morgan, David
    Kmieciak, Maciej
    Bose, Prithviraj
    Kimball, Amy
    Badros, Ashraf Z.
    Baz, Rachid
    Lin, Hui-Yi
    Zhao, Xiuhua
    Reich, Richard R.
    Tombes, Mary Beth
    Shrader, Ellen
    Sankala, Heidi
    Roberts, John D.
    Sullivan, Daniel
    Grant, Steven
    Holkova, Beata
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (09): : 569 - +
  • [40] A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
    Holkova, Beata
    Perkins, Edward B.
    Sokol, Lubomir
    Richards, Kristy L.
    Parekh, Samir
    Elstrom, Rebecca
    Badros, Ashraf Z.
    Espinoza-Delgado, Igor
    Schell, Michael J.
    Kimball, Amy
    Tombes, Mary Beth
    Shrader, Ellen
    Sankala, Heidi
    Coppola, Domenico
    Kmieciak, Maciej
    Sullivan, Daniel
    Roberts, John D.
    Grant, Steven
    BLOOD, 2011, 118 (21) : 353 - 354